Cagri Reta Dual Injection Pen Kit

Name: Cagri Reta Dual Injection Pen Kit
SKU: 86
Availability: InStock

£190.00

The Cagri Reta Dual Injection Pen Kit is a sophisticated research formulation tailored for scientific investigations into appetite control, metabolic processes, energy expenditure, and weight management strategies. This dual-pen system combines Retatrutide 40mg, a triple agonist that targets GLP-1, GIP, and glucagon receptors, with Cagrilintide 4mg, an amylin analogue, specifically designed for research protocols that explore the complementary pathways related to satiety, food consumption, and metabolic regulation.

Included in the kit are two injection pens: Pen 1 contains 40mg of Retatrutide, while Pen 2 has 4mg of Cagrilintide. The dosing increments for Retatrutide are 2.5mg, 5mg, 7.5mg, and 10mg, and for Cagrilintide, they are 0.25mg, 0.5mg, 0.75mg, and 1mg, facilitating structured dose-escalation studies. This formulation is designed for administration once a week on the same day within controlled research environments.

Each kit comes with 2 pens, 12 needles, and a comprehensive instruction booklet, offering a user-friendly platform for laboratory research into dual-mechanism appetite suppression, metabolic control, and innovative weight management studies.

Category: WEIGHT LOSS

Description
Reviews (0)

Cagri Reta Dual Injection Pen Kit

Advanced Retatrutide & Cagrilintide Research Pen System

The Cagri Reta Dual Injection Pen Kit combines Retatrutide 40mg and Cagrilintide 4mg in a convenient two-pen format designed for research applications involving metabolic regulation, appetite signaling, and weight management mechanisms. This innovative combination brings together Retatrutide, a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways, with Cagrilintide, a long-acting amylin analogue studied for its effects on satiety and energy balance.

Each kit includes one Retatrutide 40mg injection pen and one Cagrilintide 4mg injection pen, allowing researchers to investigate complementary metabolic pathways within advanced study protocols. The Retatrutide pen offers adjustable dosing increments of 2.5mg, 5mg, 7.5mg, and 10mg, while the Cagrilintide pen provides precise dosing options of 0.25mg, 0.5mg, 0.75mg, and 1mg.

Developed for laboratory and research use, the Cagri Reta Kit supports studies focused on appetite suppression, body weight regulation, metabolic health, glucose homeostasis, and hormone signaling. The complete package contains two prefilled pens, twelve disposable needles, and a detailed instruction booklet. Both formulations are designed for once-weekly administration on the same scheduled day, providing consistency for long-term research protocols.

Researchers across Europe are increasingly exploring Retatrutide and Cagrilintide combinations due to their potential to target multiple biological pathways associated with weight management, satiety, and metabolic function. The Cagri Reta Dual Injection Pen Kit offers a practical solution for advanced peptide and metabolic research programs.